Roberta La Starza Selected Research

Roberta La Starza Research Topics

Disease

9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2002
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2013 - 05/2002
8	Neoplasms (Cancer) 02/2022 - 08/2002
6	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2022 - 07/2015
5	Leukemia 01/2020 - 10/2002
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2015 - 02/2002
3	Lymphoma (Lymphomas) 01/2022 - 01/2020
3	Hypereosinophilic Syndrome (Loeffler Endocarditis) 05/2005 - 04/2004
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2007
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 08/2002
2	Pdgfra-Associated Chronic Eosinophilic Leukemia 02/2008 - 05/2005
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 03/2007 - 10/2005
1	Eosinophilia 02/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2022
1	Residual Neoplasm 01/2020
1	Hemoglobinopathies 01/2020
1	Lymphoid Leukemia 07/2015
1	Malignant Mesothelioma 03/2015
1	Sarcoma (Soft Tissue Sarcoma) 03/2015
1	Gliosarcoma 03/2015
1	Cataract (Cataracts) 01/2013
1	hereditary Hyperferritinemia with congenital cataracts 01/2013
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2009
1	Acute Myelomonocytic Leukemia 10/2007
1	Refractory Anemia 12/2004
1	Primitive Neuroectodermal Tumors (PNET) 10/2002
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2002
1	Carcinogenesis 10/2002

Drug/Important Bio-Agent (IBA)

8	nuclear pore complex protein 98IBA 07/2015 - 05/2002
4	Phosphotransferases (Kinase)IBA 01/2020 - 08/2002
3	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 02/2022 - 02/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2002
3	Imatinib Mesylate (Gleevec)FDA Link 10/2009 - 04/2004
3	Tyrosine (L-Tyrosine)FDA Link 03/2007 - 08/2002
1	Glycogen Synthase (Synthase I)IBA 06/2022
1	Small Interfering RNA (siRNA)IBA 06/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2022
1	daratumumabIBA 01/2022
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2020
1	CytokinesIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Interleukin-7 (Interleukin 7)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	venetoclaxIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	MTOR InhibitorsIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Janus Kinase InhibitorsIBA 10/2015
1	AsbestosIBA 03/2015
1	Protein Isoforms (Isoforms)IBA 03/2013
1	IronIBA 01/2013
1	ApoferritinsIBA 01/2013
1	Topoisomerase II InhibitorsIBA 10/2007
1	VimentinIBA 01/2007
1	NestinIBA 01/2007
1	Janus Kinase 2IBA 01/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2006
1	HeterochromatinIBA 10/2005
1	Genetic Markers (Genetic Marker)IBA 05/2005
1	NucleophosminIBA 01/2005
1	Contrast MediaIBA 12/2004
1	contrast agent BR1IBA 12/2004
1	Transcription Factors (Transcription Factor)IBA 10/2002
1	Dacarbazine (DIC)FDA LinkGeneric 02/2002

Therapy/Procedure

6	Therapeutics 01/2022 - 10/2007
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
1	Induction Chemotherapy 01/2020
1	Transplantation 06/2008